The diagnostic method of hepatocarcinoma summarizes _'s prevention and health care
Diagnosis in early days of hepatocarcinoma
Primary hepatocarcinoma (PLC, hereafter referred to as hepatocarcinoma) In early days diagnosis essential. From 70- 80 times of the 20th century, because of the child albumen of serum first (AFP) , the real-time supersound is apparent look like and gradual popularization of CT and employing extensively, has promoted the diagnosis in early days of hepatocarcinoma greatly. Because the diagnosing rate is obviously improved in early days, the excising rate of operation is thereupon improved, the prognosis also gets obvious improvement, the diagnosis of hepatocarcinoma, especially diagnose, it is the keys of clinic diagnosis and prognosis in early days.
In terms of early diagnosis, the hepatopathy background to the patient should fully pay attention to. 95% of the hepatocarcinoma patients in our country have hepatitis B and virus (HBV) The background infected, 10% have third liver virus (HCV) Infect the background, some patient HBV and HCV overlap infects.
Should especially pay close attention to the following dangerous crowds: Quantity getting high overlapping the infeted, wine-heading, amalgamating the intersection of glycosuria and patient and having the intersection of hepatocarcinoma and the intersection of family and history person by the intersection of HCV and the infeted, HBV and HCV year such as HBV in the middle-aged and old man. This kind of group should pay and sift checking regularly every 6 months (including serum AFP detection and ultrasonic inspection of liver) after 35- 40 years old ; Raise the liver district as presenting AFP " Location pathological change " When, should enter and diagnose the procedure immediately, observe tightly, strive to make diagnosis in early days.
Laboratory diagnostic method of hepatocarcinoma
At present, diagnosis still relies mainly on measuring serum AFP, should pay close attention to in determine the nature by the intersection of our country and hepatocarcinoma:
1. In our country, serum AFPgt of more than 60% of the hepatocarcinoma cases; 400 g/L;
2. There is not a specificity of other tumour marks that can compare favourably with AFP at present;
3. It is less likely to rely on the image to study apparatus and new technology that AFP measures.
[1] [2]Make page one
|
0 comments:
Post a Comment